ADA and systemic lupus erythematosus: On an immunological level, although both autoimmune in nature, the two diseases are characterized by different levels and quality of B cell reactivity and the propensity to respond to biotherapeutics with ADA formation in SLE compared to AAV, might be related to a more profound disruption of B cell tolerance [30, 31].